Region:Middle East
Author(s):Rebecca
Product Code:KRAC3220
Pages:87
Published On:October 2025

By Type:The market is segmented into various types of supplements, including Myo-Inositol-Based Supplements, Herbal Supplements, Vitamins and Minerals, Omega-3 Fatty Acids, Probiotics, Amino Acids, Antioxidants, and Others. Among these, Myo-Inositol-Based Supplements are leading the market due to their proven efficacy in managing insulin resistance and hormonal balance in women with PCOS. The increasing consumer preference for scientifically-backed supplements has further solidified their dominance. Globally, myo-inositol-based supplements hold the highest market share among PCOS supplements, reflecting similar trends in the UAE.

By End-User:The end-user segmentation includes Women aged 18-30, Women aged 31-45, and Women aged 46 and above. The segment of Women aged 18-30 is currently dominating the market, driven by increased awareness of PCOS and proactive health management among younger women. This demographic is more inclined to seek preventive measures and lifestyle changes, leading to a higher consumption of supplements tailored for PCOS. Younger women are also more likely to engage with digital health platforms and seek out evidence-based supplement solutions.

The UAE Polycystic Ovary Syndrome Supplements Market is characterized by a dynamic mix of regional and international players. Leading participants such as Himalaya Wellness, Theralogix, Allara Health, The S’moo Co., Fertility Family, SOVA, MyOva, Black Girl Vitamins, New Leaf Products, Zazzee Naturals, Vitabiotics Ltd., BioCare Copenhagen, Garden of Life, LLC, NOW Foods, Pure Encapsulations contribute to innovation, geographic expansion, and service delivery in this space.
The future of the UAE PCOS supplements market appears promising, driven by increasing consumer awareness and a growing focus on health and wellness. As more women seek effective management solutions for PCOS, the demand for innovative and personalized supplements is expected to rise. Additionally, advancements in technology will facilitate product development, enabling brands to cater to specific health needs, thus enhancing market dynamics and consumer engagement in the future.
| Segment | Sub-Segments |
|---|---|
| By Type | Myo-Inositol-Based Supplements Herbal Supplements Vitamins and Minerals Omega-3 Fatty Acids Probiotics Amino Acids Antioxidants Others |
| By End-User | Women aged 18-30 Women aged 31-45 Women aged 46 and above |
| By Distribution Channel | Online Retail Pharmacies Health Food Stores Supermarkets Direct Sales Others |
| By Formulation | Capsules Tablets Powders Liquids |
| By Price Range | Low Price Mid Price High Price |
| By Brand Loyalty | Brand Loyal Customers Price-Sensitive Customers New Customers |
| By Packaging Type | Bottles Blister Packs Pouches Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Healthcare Professionals | 80 | Endocrinologists, Gynecologists, General Practitioners |
| Consumers of PCOS Supplements | 120 | Women aged 18-45 diagnosed with PCOS |
| Nutritionists and Dietitians | 50 | Registered Dietitians, Nutrition Consultants |
| Pharmacy Managers | 40 | Pharmacy Managers, Retail Managers |
| Health and Wellness Influencers | 40 | Bloggers, Social Media Influencers in Health |
The UAE Polycystic Ovary Syndrome Supplements Market is valued at approximately USD 40 million, reflecting a significant growth trend driven by increased awareness of women's health issues and the rising prevalence of PCOS.